Author: Lee, Chang-Seop; Lee, Ju-Hyung; Oh, Mira; Choi, Kyung-Min; Jeong, Mi Ran; Park, Jong-Dae; Kwon, Dae Young; Ha, Ki-Chan; Park, Eun-Ock; Lee, Nuri; Kim, Sun-Young; Choi, Eun-Kyung; Kim, Min-Gul; Chae, Soo-Wan
Title: Preventive Effect of Korean Red Ginseng for Acute Respiratory Illness: A Randomized and Double-Blind Clinical Trial Document date: 2012_12_7
ID: v07crluc_20
Snippet: Statistical analysis was done by a statistician under blinded conditions. The efficacy analysis was done only with subjects who completed the study (per protocol, PP group), whereas the frequency rate of ARI was done using the Fisher's exact test. Symptom duration and score were analyzed with the Mann Whitney U test and Fisher's exact test. The safety assessment was also done only with subjects that completed the study (per protocol, PP group), a.....
Document: Statistical analysis was done by a statistician under blinded conditions. The efficacy analysis was done only with subjects who completed the study (per protocol, PP group), whereas the frequency rate of ARI was done using the Fisher's exact test. Symptom duration and score were analyzed with the Mann Whitney U test and Fisher's exact test. The safety assessment was also done only with subjects that completed the study (per protocol, PP group), and the analysis between the two groups were done using the Mann Whitney U test and Fisher's exact test. We used the repeated measure analysis of variance (ANOVA) to compare the laboratory findings between two groups before and after clinical trial. SPSS software ver 19.0 (SPSS Inc., Chicago, IL, USA) was used for all analyses and P values of less than 0.05 were considered statistically significant.
Search related documents:
Co phrase search for related documents- group analysis and PP group: 1, 2, 3, 4
- group analysis and score symptom duration: 1
- group analysis and statistical analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66
- group analysis and symptom duration: 1, 2, 3
- group laboratory finding and laboratory finding: 1
- laboratory finding and PP group: 1
- laboratory finding and statistical analysis: 1
- laboratory finding and symptom duration: 1
- Mann Whitney test and PP group: 1
- Mann Whitney test and score symptom duration: 1
- Mann Whitney test and statistical analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- Mann Whitney test and symptom duration: 1
- Mann Whitney test and USA IL Chicago SPSS analysis: 1, 2, 3, 4
- PP group and statistical analysis: 1, 2
- safety assessment and statistical analysis: 1, 2
- score symptom duration and statistical analysis: 1
- score symptom duration and symptom duration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- statistical analysis and symptom duration: 1, 2, 3, 4, 5, 6
- statistical analysis and USA IL Chicago SPSS analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
Co phrase search for related documents, hyperlinks ordered by date